19 results
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
Summary of dosing ... commonly used hypoglycaemic ... #Medications #Pharmacology ... #Dosing #Dosing ... CKD #Table #GFR #Hypoglycemics
Pediatric Dextrose Administration in Hypoglycemia 

#Dextrose #Hypoglycemia #Peds #Pediatrics #Formula #Pharmacology
Administration in Hypoglycemia ... #Dextrose #Hypoglycemia ... #Peds #Pediatrics ... #Formula #Pharmacology
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... or anti-hyperglycemic ... and compares the hypoglycemia ... #pharmacology #pharmacotherapy ... #table #comparison
Sulfonylureas - Pharmacology Summary
Mechanisms of Action: Binds to the ATP-sensitive potassium channel in pancreatic beta cells,
Sulfonylureas - Pharmacology ... : Weight gain, Hypoglycemia ... Sulfonylureas #Pharmacology ... #Summary #DM2 #
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... Does not cause hypoglycemia ... mL/minute/1.73 m2 ... #Metformin #Pharmacology ... #Summary #DM2 #
Pathophysiology of Diabetic Ketoacidosis (DKA) and Hyperglycemic Hyperosmolar Syndrome (HHS)
Absolute Insulin deficit:
 - Type I DM:
Ketoacidosis (DKA) and Hyperglycemic ... deficit: - Type I DM ... food binges, etc Hyperglycemia ... pathophysiology #comparison ... #ketoacidosis #hyperglycemic
Octreotide for sulfonylurea-induced hypoglyemia 

#Octreotide #sulfonylurea #hypoglyemia #Toxicology #Pharmacology #Management #Dosing
sulfonylurea-induced hypoglyemia ... #sulfonylurea #hypoglyemia ... #Toxicology #Pharmacology ... #Management #Dosing
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
Oral Hypoglycemics ... AmyChung #Oral #Hypoglycemics ... Diabetes #Management #pharmacology ... #DM2 #DMII #Classification
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Normal and Renal Dosing ... minimal chance of hypoglycemia ... Inhibitors #Renal #Dosing ... #Pharmacology # ... Management #Diabetes #DM2
Insulin Degludec (Tresiba) vs Insulin Glargine (Lantus, Basaglar, or Toujeo)

Insulin degludec (Tresiba) is an ultra-long acting
do require BID dosing ... incidence of severe hypoglycemia ... Degludec #Glargine #Comparison ... #Pharmacology #